Akoya Biosciences AKYA 深 沪
等待开盘 04-03 09:30:00 美东时间
1.29
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.29
- 总市值 6444.09万
- 52周最高 3.42
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.931
- 委 比 0.00%
- 总股本 4995.42万
- 历史最高 28.956
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.931
- 每 手 1
- 风险率 0.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Quanterix Q2 revenue falls 29%, net loss widens
Overview Quanterix Q2 2025 revenue falls 29% yr/yr, net loss widens significantly Company completed acquisition of Akoya Biosciences, aiming for cash flow breakeven by 2026 Alzheimer's Diagnostics rev...
2025-08-08 05:00
Quanterix Reports Q2 Net Loss of $30M, Alzheimer's Diagnostics Revenues More Than Tripled Year-Over-Year
Quanterix Corporation (NASDAQ: QTRX) reported its financial results for the second quarter ended June 30, 2025, revealing a net loss of $30.0 million, compared to a net loss of $7.4 million in the sam...
2025-08-08 04:26
Quanterix Unveils Novel p-Tau 205 And 212 Biomarker Assays, Expanding Blood-Based Alzheimer's Detection Portfolio
Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa® technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on
2025-07-28 19:20
BRIEF-Quanterix Terminates Executives Of Akoya Biosciences
July 18 (Reuters) - Quanterix Corp QTRX.O: QUANTERIX CORP - ON JULY 14, TERMINATES EXECUTIVES OF AKOYA BIOSCIENCES - SEC FILING QUANTERIX CORP - TERMINATIONS EXPECTED TO SAVE $2.8 MILLION ANNUALLY - S...
2025-07-19 06:26
快讯 | Quanterix CORP - 7月14日，终止Akoya Biosciences的高管职务 - SEC文件
Quanterix Corp - on July 14, Terminates Executives of Akoya Biosciences - SEC F...
2025-07-19 04:38
Akoya Biosciences Completes Merger and Nasdaq Delisting
Akoya Biosciences ( ($AKYA) ) has issued an update. On July 8, 2025, Akoya Bios...
2025-07-08 21:43
Quanterix Completes Acquisition of Akoya Biosciences
An announcement from Quanterix ( ($QTRX) ) is now available. On July 8, 2025, Q...
2025-07-08 21:28
Quanterix Corporation Announces New Board Members as Mendel and Lai-Goldman Join Leadership Team Following Akoya Acquisition
Quanterix Corporation has announced changes to its Board of Directors following the acquisition of Akoya Biosciences. Scott Mendel and Myla Lai-Goldman, MD, have been appointed to the board, replacing...
2025-07-08 21:07
Akoya Biosciences Inc. Conducted Special Stockholders Meeting
Akoya Biosciences Inc. held a special meeting of stockholders on July 7, 2025. Stockholders approved the proposal to adopt the Amended and Restated Agreement and Plan of Merger involving Quanterix Cor...
2025-07-08 04:05
Akoya Biosciences Receives Unsolicited Acquisition Proposal Amid Merger Talks with Quanterix
Akoya Biosciences Inc. announced that it received an unsolicited acquisition proposal from a third party, referred to as Party A, to acquire the company in an all-cash tender offer. The proposal offer...
2025-06-03 04:06
